Related Experiment Videos
Non-Hodgkin's lymphoma: long-term survivors and adverse effects
1Department of Oncology, Rambam Medical Center, Haifa, Israel.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
British journal of cancer·2014
Enzyme-linked-immunosorbent-assay for the detection of a novel 21-kda protein associated with the clinical course of patients with urogenital tumors.
International journal of oncology·2011
Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
Current medicinal chemistry·2010
Diagnosis and treatment of primary non-Hodgkin's lymphoma of the parotid gland: a retrospective study - Experience at the Northern Israel Oncology Center (1977-1999).
Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2007
Primary lymphoma of the liver: clinical features and outcome of 9 patients.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2007
Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma.
The American Journal of dermatopathology·2006
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026